Introduction
In the recent Urticaria Centers of Reference and Excellence (UCARE)
study, CURICT, we assessed use and interest in information and
communications technologies (ICTs) for patients with chronic urticaria
(CU).1,2 We found that almost all CU patients had
access to ICTs and most were using these regularly to obtain health and
disease-related information.1 Specifically, most
patients with CU were interested in ICTs to receive disease information
and to communicate with their physicians and other patients about their
urticaria.2
ICTs such as mobile phone applications (apps) would enable patients to
(i) self-evaluate their disease activity, impact, and control, (ii)
improve self-management and (iii) optimize their therapy including
allergic comorbidities. Yet, very recently Antó et al (2021) reported a
global paucity of such apps for patients with CU.3 To
date, the unmet need for suitable apps from the patient’s point of view
remains unknown.
Objective: Using questions from the CURICT study, we assessed
patient interest in using apps to monitor CU disease activity and
control.